Movatterモバイル変換


[0]ホーム

URL:


US2799241A - Means for applying coatings to tablets or the like - Google Patents

Means for applying coatings to tablets or the like
Download PDF

Info

Publication number
US2799241A
US2799241AUS335527AUS33552753AUS2799241AUS 2799241 AUS2799241 AUS 2799241AUS 335527 AUS335527 AUS 335527AUS 33552753 AUS33552753 AUS 33552753AUS 2799241 AUS2799241 AUS 2799241A
Authority
US
United States
Prior art keywords
tablets
air
chamber
coating
screen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US335527A
Inventor
Dale E Wurster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Research FoundationfiledCriticalWisconsin Alumni Research Foundation
Priority to US335527ApriorityCriticalpatent/US2799241A/en
Application grantedgrantedCritical
Publication of US2799241ApublicationCriticalpatent/US2799241A/en
Anticipated expirationlegal-statusCritical
Expired - Lifetimelegal-statusCriticalCurrent

Links

Images

Classifications

Definitions

Landscapes

Description

. i. (Jigy 9 D. E. WURSTER 2,799,241
MEANS FOR APPLYING COATINGS TO TABLETS OR THE LIKE Original Filed Jan. 21, 1949 RECOVERY Am: I Ex www- ALONG WALL OF 10 A Cum-1m: CHAMBER 6 'llbfibhhdr Q 7 3 INLET Compnzssco 2 POWDERED AIR Lac-rose ACACIA SOLUTION o HEATmr: 5UGAR Emmanu- Soun-lon Ram CAOMPRESSEO OUTLET To POLISHING 22 PAN AIR
IN VEN TOR.
United States Patent MEANS FOR APPLYING COATINGS TO TABLETS OR THE LIKE Dale E. Wurster, Madison, Wis,
Alumni Research Foundation, Madison, ration of Wisconsin assignor to Wisconsin =Wis., a corpo- 21, 1949, Serial No. 71,977, dated August 11, 1953. Di-
Serial No.
8 Claims. (Cl. 118-24) My invention relates, generally, to methods of and means for applying coatings, and it has particular relation to the coating of medicinal tablets, chewing gum, candy, nuts, etc. This application is a division of application Serial No. 71,997, filed January 21, 1949, now Patent No. 2,648,609, issued August ll, 1953.
Among the objects of my invention are: To support the tablets in air in a coating chamber and to coat the same while they are so positioned; to support the tablets in an upwardly flowing air stream; to 'heat the air prior to its contact with the tablets to dry the coating thereon; to cause the air to flow in a turbulent fashion and tumble the tablets so that they may be coated uniformly; to move the tablets downwardly on a bias transversely of the air stream while they are being coated; to introduce the coating material into the air stream underneath its initial contact point with the tablets; to introduce individually into the air stream different coating materials; and to direct a current of air upwardly in the coating chamber along its inner surface to prevent the coating material from impinging .thereon.
Other objects of my invention will, and in part appear hereinafter.
This invention is disclosed in the embodiment thereof shown in the accompanying drawing and it comprises the features of construction, combination of elements and arrangement of parts which will be set forth in detail hereinafter and the scope of .the application of which will be indicated in the appended claims.
For a more complete understanding of the nature and scope of my invention, reference can be had to the following detailed description, taken together with the accompanying drawing, in which:
Figure 1 is a longitudinal-sectional view of a coating mechanism constructed ,in accordance with my invention;
Figure 2 is a view partly in section and partly in elevain part, be obvious 2,799,241 Patented July 16, 1957tube 17 may discharge into a polishing pan .or similar receptacle.Slides 18 and 19 may be provided in theoutlet tube 17 for controlling the flow of the coated tab lets therethrough in batches similar to the manner in which they are permitted to flow onto thescreen 15 by theslides 13 and 14.
It is desirable that the uncoated and partially coated tablets above thescreen 15 be supported in air so that they can be evenly coated. For thispurpose air jets 20 and 21 are positioned in the lower end of thechamber 10 below thescreen 15 and are directed upwardly to supply an air stream flowing upwardly in thechamber 10 of sufiicient velocity to maintain the uncoated and partially coated tablets slightly out of contact with thescreen 15. Theair jets 20 and 21 may be connected by conduits 20' and 21 to a suitable source of compressed air, the pressure of which is adjusted so as to maintain the 111117 coated and partially coated tablets slightly above thescreen 15 to be coated in a manner to be described presently.
Not only is it desirable that the tablets be supported in the air stream which flows upwardly through thecoating chamber 10 but also it is desirable that they be tumbled so as .to coat the same more uniformly. For this purpose the flow of air through thecoating chamber 10 is arranged so that, in place of it being a streamlined flow, it is a turbulent flow. For this purpose adisc 22 is provided which may be rotated at ,a constantspeed by ,amotor 23. As shown more clearly in Figure 3 the.disc 22 hascircular rows 24, 25, 26, and :27 of perforations through whichthe air from thejets 20 and 21 flows. As shown in Figure 1 theair jets 20 and 21 register with the circular rows 24, '25, '26 and 27 of perforations .so that the air from the former is directed by the row of perforations individual thereto. Also as shown in Figure '1 the rows 24 and 27 of the perforations are inclined-inwardly while the row 25 of perforations is inclined outwardly. Theremaining row 26 extends vertically through thedisc 22. The several air streams thus directed by theperforations 24, 25, 26, and 27 impinge on the uncoated and partially coated tablets above thescreen 15 in a turbulent fashionand cause them-to be tumbled so thatthey tion at an enlarged scale showing in more detail the construction of the manifold which directs air upwardly along the inner surface of the coating chamber; and
Figure 3 is a top plan view of the rotating disc which causes the air to flow in a turbulent fashion.
Referring now particularly to'the drawing, it will be observed that thereference character 10 designates a vertically positioned coating chamber which may be formed of metal or glass. Thecoating chamber 10 preferably has a circular cross section, and it may be of conical, modified conical, or cylindrical shape as may be desired. Near its lower end there is provided anentrance 11 for the tablets to be coated. Aninlet tube 12 communicates with theentrance 11 andslides 13 and 14 are positioned therein to permit the introduction of the tablets to be coated into thechamber 10 in batches.
Within thechamber 10 there is ascreen 15 which extends transversely thereacross and on a bias so that the tablets to be coated, and while they are being coated, move across thechamber 10 and downwardly to anexit 16 with which anoutlet tube 17 communicates. The
can be evenly and completely coated with the coating material.
With a view to dryingquickly the coating material on the tablets, provision is made for heating the air as it passes upwardly through the :chamber 10 underneath thescreen 15. For this purpose an electric heater element 28,in the form of a grid, may be positioned immediately above the rotatingdisc 22. It will be understood that the heater element 28 may be connected for energization to a suitable current source and .that the degree of heat can be varied by varying the amount of current flowing therethrough.
mined'by the number of -.different.coating materials -to be employed. Each of itheconduits ;30, 31 and :32 terminates in a nozzle 33 which, as shown in Figure l, is directed against the tablets near the upper edge of thescreen 15 so that the coating material is supplied to the tablets as soon as they pass through theentrance 11. It will be understood that various coating materials can be supplied. As illustrated in Figure 1, theconduit 30 is arranged to have powdered lactose blown therethrough. Theconduit 31 carries an acacia solution, while theconduit 32 may carry a sugar solution. It will be understood that these particular materials are mentioned for illustrative purposes only and that other coating materials can be used as may be desired.
Certain of the coating materials may tend to adhere to the inner surface of the coating chamber particularly in the immediate vicinity of thescreen 15. In order to prevent this a ring-like manifold 34 may be positioned just above thescreen 15. As shown in Figure 2 themanifold 34 has outwardly and upwardly directed openings orapertures 35 which cause air supplied to themanifold 34 from a suitable source of compressed air to flow in the directions indicated by thearrows 36 over the inner surface of thechamber 10 for preventing the coating material from engaging the same.
At the upper end of the coating chamber 10 ascreen 37 may be provided to prevent the escape of tablets in the event that the pressure supplied through the jets and 21 should be sufficiently great as to cause them to rise to this position. Anexhaust tube 38 connects thecoating chamber 10 to a suitable recovery and exhaust chamber as will be understood readily.
In operation, themotor 23 is energized to drive thedisc 22 at the desired speed. Air under pressure is supplied through the conduits 20' and 21' to thejets 20 and 21 respectivelyso that the uncoated and partially coated tablets on thescreen 15 will be tumbled thereabove. This air pressure also is adjusted so that when the tablets are fully coated it will be insufiicient to maintain them above thescreen 15 at the lower end thereof adjacent theexit 16. The current flowing through the heating element 28 is adjusted so that the coating applied to the tablets above thescreen 15 is dried satisfactorily. The coating materials supplied to theconduits 30, 31 and 32 are arranged and adjusted so that the desired proportions will be applied to the tablets at rates which will provide the desired thickness of coating. Air is supplied to themanifold 34, it being understood that the pressure at theapertures 35 therein is slightly greater than the air pressure at theair jets 20 and 21 so that the desired air flow takes place along the inner surface of thechamber 10 to prevent the coating material from impinging thereon.
Now, theslide 13 is raised to permit a charge of uncoated tablets to flow downwardly through theinlet tube 12 against the slide 14. Theslide 13 is closed and then the slide 14 is opened. The uncoated tablets flow through theentrance 11 onto the upper end of thescreen 15 and are immediately lifted thereabove and tumbled. At the same time they are subjected to the atomized flow of coating materials from the nozzles 33 which are supplied individually by theconduits 30, 31 and 32 in the manner described. The partially coated tablets move transversely of thechamber 10 and downwardly on a bias but are still being tumbled above thescreen 15 until the coating thereon is sufliciently heavy so that the upwardly flowing air stream is insufiicient to maintain them out of contact with thescreen 15. When all of the tablets have been completely coated, theslide 18 is opened and they are allowed to discharge through theexit 16 into theoutlet tube 17. Thereafter theslide 18 is closed and theslide 19 is opened to permit the coated tablets to be discharged into the polishing pan or other receptacle as may be desired.
It will be obvious that certain changes can be made in the foregoing construction without departing from the spirit and scope of this invention. Accordingly, it is intended that all matter shown in the accompanying drawing and described hereinbefore shall be interpreted as illustrative and not in a limiting sense.
I claim as my invention:
1. Apparatus for coating tablets or the like comprising, in combination, a vertically disposed coating chamber, screen means extending transversely of said chamber at its lower end for receiving the tablets to be coated, means for directing an air stream through said chamber in a vertical direction to react against the under sides of the tablets and suspend them in the lower part of said chamber against the force of gravity above said screen, and conduit means extending into said chamber for introducing the coating material into the air stream below the suspended tablets.
2. The invention, as set forth in claim 1, wherein means are provided for heating the air stream prior to contact with the tablets to dry quickly the coating applied thereto.
3. The invention, as set forth in claim 2, wherein means are provided to cause the air stream to flow turbulently to tumble the tablets so that they are coated uniformly.
4. The invention, as set forth in claim 1, wherein the screen means is disposed on a bias in the coating chamber, an entrance for the uncoated tablets is provided through the wall of said chamber at the top of said screen means, and an exit for the coated tablets is provided through the wall of said chamber at the bottom of said screen means.
51 The invention, as set forth in claim 4, wherein the conduit means discharges the coating material into the air stream near the top of the screen means and the velocity of the air stream is such that the uncoated and partially coated tablets are tumbled while the fully coated tablets are too heavy to be tumbled and fall to the lower end of said screen means.
6. The invention, as set forth in claim 1, wherein the conduit means comprises a plurality of conduits each arranged to introduce a separate coating material into the air stream.
7. The invention, as set forth in claim 1, wherein means are provided for directing a flow of air upwardly along the inner surface of the coating chamber above the screen means to prevent the coating material from impinging on said surface.
8. The invention, as set forth in claim 7, wherein the pressure at which the air is directed upwardly along the inner surface of the housing is greater than the pressure at which the air stream is directed upwardly for the support of the tablets.
References Cited in the file of this patent UNITED STATES PATENTS 1,473,165 Steigmeyer Nov. 6, 1923 1,546,922 Faber July 21, 1925 1,854,100 Brito Apr. 12, 1932 2,114,377 Goss Apr. 19, 1938 2,227,465 Roche et al. Jan. 7, 1941 2,339,932 Kuhl Jan. 25, 1944 2,561,392 Marshall July 24, 1951 2,563,475 Mahoney Aug. 7, 1951 2,648,609 Wurster Aug. 11, 1953
US335527A1949-01-211953-02-06Means for applying coatings to tablets or the likeExpired - LifetimeUS2799241A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
US335527AUS2799241A (en)1949-01-211953-02-06Means for applying coatings to tablets or the like

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
US7197749A1949-01-211949-01-21
US335527AUS2799241A (en)1949-01-211953-02-06Means for applying coatings to tablets or the like

Publications (1)

Publication NumberPublication Date
US2799241Atrue US2799241A (en)1957-07-16

Family

ID=26752886

Family Applications (1)

Application NumberTitlePriority DateFiling Date
US335527AExpired - LifetimeUS2799241A (en)1949-01-211953-02-06Means for applying coatings to tablets or the like

Country Status (1)

CountryLink
US (1)US2799241A (en)

Cited By (185)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US2944512A (en)*1956-07-171960-07-12Martin CoMethod and apparatus for spray painting small articles
US2986475A (en)*1958-11-051961-05-30Smith Kline French LabApparatus and method for coating discrete solids
US3075885A (en)*1957-07-121963-01-29Marissal GeorgesProcess for the stabilization by physical means of thermomineral planktonic complexes
US3089824A (en)*1959-04-301963-05-14Wisconsin Alumui Res FoundatioGranulating and coating process for uniform granules
US3106492A (en)*1961-09-011963-10-08Upjohn CoApparatus for coating discrete solids
DE1158481B (en)*1959-11-091963-12-05Wisconsin Alumni Res Found Process for coating particles with a coating material in a fluidized bed
US3117027A (en)*1960-01-081964-01-07Wisconsin Alumni Res FoundApparatus for coating particles in a fluidized bed
US3132075A (en)*1960-10-171964-05-05Upjohn CoSolid medicinal dosage forms coated with hydroxyethylcellulose and hydrolyzed styrene-maleic anhydride copolymer
US3145146A (en)*1961-10-311964-08-18Warner Lambert PharmaceuticalModified mannitol for pharmaceutical tablets
US3148070A (en)*1961-03-241964-09-08Afico SaAromatization of powdered coffee products
DE1184459B (en)*1962-01-201964-12-31Boehringer & Soehne Gmbh Coating process
US3177845A (en)*1960-07-111965-04-13Wood B HedgepethDevice for cooling and finishing foods
DE1205497B (en)*1960-02-261965-11-25Abbott Lab Method of applying a coating to finely divided discrete, preferably fragile, particles
US3253944A (en)*1964-01-131966-05-31Wisconsin Alumni Res FoundParticle coating process
US3357398A (en)*1962-09-281967-12-12Abbott LabMethod and apparatus for coating tablets
US3411480A (en)*1964-01-311968-11-19Smith Kline French LabDevice for coating fine solids
US3533829A (en)*1965-12-141970-10-13Azote & Prod ChimProcess and apparatus for solidifying and granulating a paste
US3880116A (en)*1974-02-141975-04-29Arnar Stone LabParticle coating apparatus
US4044713A (en)*1974-02-201977-08-30Zenyaku Kogyo Kabushiki KaishaTumbing apparatus
US4141316A (en)*1976-01-231979-02-27Gustav GrunApparatus for the treatment of powdery or granular material
US4615698A (en)*1984-03-231986-10-07Alza CorporationTotal agent osmotic delivery system
US4639383A (en)*1983-09-201987-01-27Thomas Engineering, Inc.Method and apparatus for coating particulate granules
AT385169B (en)*1984-11-201988-02-25Thaelmann Schwermaschbau VebMethod for the treatment of plant seeds
AT385170B (en)*1984-11-201988-02-25Thaelmann Schwermaschbau VebMethod for the application of agricultural chemicals to seeds
US4764380A (en)*1982-03-221988-08-16Alza CorporationDrug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
US4772477A (en)*1986-10-171988-09-20Balchem CorporationMeat acidulant
US4801461A (en)*1987-01-281989-01-31Alza CorporationPseudoephedrine dosage form
US4803092A (en)*1986-10-171989-02-07Balchem CorporationMethod of acidulating a comminuted meat product
US4851232A (en)*1987-02-131989-07-25Alza CorporationDrug delivery system with means for obtaining desirable in vivo release rate pattern
US4915952A (en)*1987-02-271990-04-10Alza CorporationComposition comprising drug, HPC, HPMC and PEO
US4931285A (en)*1988-04-281990-06-05Alza CorporationAqueous based pharmaceutical coating composition for dosage forms
US4969884A (en)*1988-12-281990-11-13Alza CorporationOsmotically driven syringe
US5019396A (en)*1989-05-121991-05-28Alza CorporationDelivery dispenser for treating cardiac arrhythmias
US5018909A (en)*1990-04-131991-05-28Nordson CorporationPowder feed hopper
US5023076A (en)*1987-02-271991-06-11Alza CorporationLamina comprising carboxyvinyl polymer
US5024843A (en)*1989-09-051991-06-18Alza CorporationOral hypoglycemic glipizide granulation
US5024842A (en)*1988-04-281991-06-18Alza CorporationAnnealed coats
US5035897A (en)*1989-09-051991-07-30Alza CorporationDosage form for delivering soluble or insoluble drugs
US5091190A (en)*1989-09-051992-02-25Alza CorporationDelivery system for administration blood-glucose lowering drug
US5096716A (en)*1988-09-011992-03-17Alza CorporationDosage form for administering calcium antagonist nicardipine
US5098714A (en)*1989-11-161992-03-24Alza CorporationOsmotic, oral dosage form for fertility control
US5166145A (en)*1990-09-101992-11-24Alza CorporationAntiemetic therapy
US5178867A (en)*1991-08-191993-01-12Alza CorporationDosage form for delivering drug in short-time period
US5185158A (en)*1992-02-271993-02-09Alza CorporationDosage form comprising succinimide drug for treating depressive disorders and composition comprising same
US5186942A (en)*1989-01-301993-02-16Alza CorporationNicardipine therapy
US5190775A (en)*1991-05-291993-03-02Balchem CorporationEncapsulated bioactive substances
US5200194A (en)*1991-12-181993-04-06Alza CorporationOral osmotic device
US5200197A (en)*1989-11-161993-04-06Alza CorporationContraceptive pill
US5207933A (en)*1991-08-281993-05-04The Procter & Gamble CompanyLiquid fabric softener with insoluble particles stably suspended by soil release polymer
US5232612A (en)*1991-08-281993-08-03The Procter & Gamble CompanySolid, particulate fabric softener with protected, dryer-activated, cyclodextrin/perfume complex
US5232613A (en)*1991-08-281993-08-03The Procter & Gamble CompanyProcess for preparing protected particles of water sensitive material
US5234611A (en)*1991-08-281993-08-10The Procter & Gamble CompanyFabric softener, preferably liquid, with protected, dryer-activated, cyclodextrin/perfume complex
US5236615A (en)*1991-08-281993-08-17The Procter & Gamble CompanySolid, particulate detergent composition with protected, dryer-activated, water sensitive material
US5246711A (en)*1992-02-271993-09-21Alza CorporationDosage form for treating dysthymia
US5246710A (en)*1992-02-271993-09-21Alza CorporationDosage form for treating cyclothymia
US5254168A (en)*1992-06-041993-10-19Howard LittmanCoating apparatus having opposed atomizing nozzles in a fluid bed column
US5296219A (en)*1990-06-151994-03-22Rhone-Poulenc Nutrition AnimaleProcess for coating active principles using a pH-sensitive polymer
EP0588707A1 (en)1992-09-181994-03-23Rhone-Poulenc Nutrition AnimaleChitosan-based nutrient and drug compositions for administration to ruminants
US5330762A (en)*1992-02-271994-07-19Alza CorporationTandospiaine antidepressive therapy
US5350659A (en)*1993-03-311994-09-27Xerox CorporationPreparation of conductive toners using fluidized bed processing equipment
US5358721A (en)*1992-12-041994-10-25Alza CorporationAntiviral therapy
US5532003A (en)*1994-01-181996-07-02Alza CorporationPentoxifylline therapy
US5540665A (en)*1994-01-311996-07-30Alza CorporationGas driven dispensing device and gas generating engine therefor
US5567238A (en)*1994-12-061996-10-22Coating Machinery Systems, Inc.Oscillating bed seed coating machine for particulate material
US5591454A (en)*1989-09-051997-01-07Alza CorporationMethod for lowering blood glucose
US5595759A (en)*1994-11-101997-01-21Alza CorporationProcess for providing therapeutic composition
US5614578A (en)*1994-10-281997-03-25Alza CorporationInjection-molded dosage form
US5616339A (en)*1992-09-181997-04-01Rhone-Poulenc Nutrition AnimaleChitosan-based nutrient or medicinal compositions for administration to ruminants
US5620705A (en)*1994-08-041997-04-15Alza CorporationProgestin tablet
US5660861A (en)*1994-04-281997-08-26Alza CorporationEffective therapy for epilepsies
US5688518A (en)*1992-02-271997-11-18Alza CorporationAntidepressive therapy
US5698224A (en)*1994-06-271997-12-16Alza CorporationTacrine therapy
US5707663A (en)*1993-05-281998-01-13Alza CorporationSustained antiepileptic therapy
US5858407A (en)*1992-02-271999-01-12Alza CorporationMethod for administering tandospirone
US6056992A (en)*1988-06-022000-05-02Campbell Soup CompanyEncapsulated additives
US6110499A (en)*1997-07-242000-08-29Alza CorporationPhenytoin therapy
US6124355A (en)*1995-05-222000-09-26Guittard; George V.Oxybutynin therapy
WO2000062830A3 (en)*1999-04-192000-12-28Scimed Life Systems IncCoating medical devices using air suspension
US6210712B1 (en)1997-12-052001-04-03Alza CorporationDosage form having first and second coats
US6262115B1 (en)1995-05-222001-07-17Alza CoporationMethod for the management of incontinence
US20010009995A1 (en)*1998-03-262001-07-26Gupta Suneel K.Oxybutynin therapy
US6312521B1 (en)1998-12-142001-11-06Primera Foods CorporationApparatus and process for coating particles
US20010038856A1 (en)*1994-07-072001-11-08Sonya MerrillHydromorphone therapy
US6342249B1 (en)1998-12-232002-01-29Alza CorporationControlled release liquid active agent formulation dosage forms
US6361795B1 (en)1989-09-052002-03-26Alza CorporationMethod for lowering blood glucose
US20020048600A1 (en)*1998-11-022002-04-25Padmanabh BhattControlled delivery of active agents
US6379498B1 (en)2000-02-282002-04-30Kimberly-Clark Worldwide, Inc.Method for adding an adsorbable chemical additive to pulp during the pulp processing and products made by said method
US20020071863A1 (en)*1999-12-092002-06-13Dong Liang C.Antiviral medication
US20020098242A1 (en)*1997-07-312002-07-25Darder Carlos PicornellOral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production
US6440457B1 (en)1993-05-272002-08-27Alza CorporationMethod of administering antidepressant dosage form
US20020160045A1 (en)*1998-06-052002-10-31Desjardin Michael A.Therapeutic dosage form for delivering oxybutynin
US6514530B2 (en)1997-09-092003-02-04Alza CorporationDosage form comprising means for changing drug delivery shape
US20030062641A1 (en)*2001-08-162003-04-03Niraj VasishthaMicroencapsulation using electromagnetic energy and core and shell materials with different dielectric constants and dissipation factors
US6582560B2 (en)2001-03-072003-06-24Kimberly-Clark Worldwide, Inc.Method for using water insoluble chemical additives with pulp and products made by said method
US20030125714A1 (en)*2001-12-182003-07-03Edgren David EmilDosage form for time-varying patterns of drug delivery
US20030165614A1 (en)*2002-03-012003-09-04Henrik HansenCoating a medical implant using a pan coater
US20030198619A1 (en)*2001-12-192003-10-23Dong Liang C.Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
US20030224051A1 (en)*2002-05-312003-12-04Fink Tracy A.Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
US20030232078A1 (en)*2001-12-192003-12-18Dong Liang C.Formulation & dosage form for the controlled delivery of therapeutic agents
US20040010000A1 (en)*2002-04-292004-01-15Ayer Atul D.Methods and dosage forms for controlled delivery of oxycodone
US6685775B1 (en)2002-02-192004-02-03Vector CorporationWurster air diverter
US20040045687A1 (en)*2002-09-112004-03-11Shannon Thomas GerardMethod for using water insoluble chemical additives with pulp and products made by said method
US6706282B1 (en)1998-11-022004-03-16Evangeline CruzControlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
US20040062799A1 (en)*1997-09-292004-04-01Ayer Atul D.Therapeutic composition and delivery system for administering drug
US6730349B2 (en)1999-04-192004-05-04Scimed Life Systems, Inc.Mechanical and acoustical suspension coating of medical implants
US20040091529A1 (en)*2002-06-262004-05-13David EdgrenMethods and dosage forms for increasing solubility of drug compositions for controlled delivery
US6740406B2 (en)2000-12-152004-05-25Kimberly-Clark Worldwide, Inc.Coated activated carbon
US20040115315A1 (en)*2002-08-022004-06-17Camelot Damien Michel AndreEncapsulated crystalline lactic acid
US20040115262A1 (en)*2002-07-292004-06-17Frank JaoFormulations and dosage forms for controlled delivery of topiramate
US6767553B2 (en)2001-12-182004-07-27Kimberly-Clark Worldwide, Inc.Natural fibers treated with acidic odor control/binder systems
US20040166160A1 (en)*2003-01-142004-08-26Ramkumar SubramanianMethods and dosage forms with modified viscosity layers
US20040191314A1 (en)*1994-04-282004-09-30Frank JaoAntiepileptic dosage form and process for protecting antiepileptic drug
US20040197407A1 (en)*2003-02-112004-10-07Ramkumar SubramanianMethods and dosage forms with modified layer geometry
US20050003006A1 (en)*1997-09-092005-01-06Alza CorporationPharmaceutical coating composition and method of use
US20050025832A1 (en)*1996-11-122005-02-03Alza CorporationMethods and devices for providing prolonged drug therapy
US6852904B2 (en)2001-12-182005-02-08Kimberly-Clark Worldwide, Inc.Cellulose fibers treated with acidic odor control agents
US20050058707A1 (en)*2003-08-062005-03-17Iran ReyesUniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
US20050069587A1 (en)*2003-09-022005-03-31Modi Nishit BachulalNovel drug compositions and dosage forms of topiramate
US20050089570A1 (en)*2003-09-262005-04-28Evangeline CruzOros push-stick for controlled delivery of active agents
US20050106249A1 (en)*2002-04-292005-05-19Stephen HwangOnce-a-day, oral, controlled-release, oxycodone dosage forms
US20050112195A1 (en)*2003-09-262005-05-26Evangeline CruzDrug coating providing high drug loading and methods for providing same
US20050136108A1 (en)*2003-08-222005-06-23Yam Noymi V.Stepwise delivery of topiramate over prolonged period of time
US20050148594A1 (en)*2002-12-172005-07-07Cink Russell D.Salts of fenofibric acid and pharmaceutical formulations thereof
US20050158382A1 (en)*2003-09-262005-07-21Evangeline CruzControlled release formulations of opioid and nonopioid analgesics
US20050169992A1 (en)*2003-12-232005-08-04Frank JaoMethods and dosage forms for increasing solubility of drug compositions for controlled delivery
US20050175697A1 (en)*2003-12-292005-08-11David EdgrenNovel drug compositions and dosage forms of topiramate
US20050175696A1 (en)*2003-12-292005-08-11David EdgrenDrug granule coatings that impart smear resistance during mechanical compression
US20050175690A1 (en)*2003-12-292005-08-11David EdgrenNovel drug compositions and dosage forms
US20050220879A1 (en)*1999-12-162005-10-06Alza CorporationDosage forms having a barrier layer to laser ablation
US20050232995A1 (en)*2002-07-292005-10-20Yam Nyomi VMethods and dosage forms for controlled delivery of paliperidone and risperidone
US20050287213A1 (en)*2004-06-282005-12-29Wong Patrick SDosage forms for low solubility and or low dissolution rate free acid pharmaceutical agents
US20050287212A1 (en)*2004-06-282005-12-29Liang-Chang DongOral delivery system comprising a drug/polymer complex
US20060009425A1 (en)*2004-05-282006-01-12Leticia Delgado-HerreraOral formulations of paricalcitol
US20060057206A1 (en)*2004-08-192006-03-16Wong Patrick SControlled release nanoparticle active agent formulation dosage forms and methods
US7060734B1 (en)1997-09-092006-06-13Alza CorporationPharmaceutical coating composition and method of use
WO2006061576A1 (en)*2004-12-112006-06-15Apv Systems LimitedFood item coating apparatus and method
US20060134196A1 (en)*2002-12-172006-06-22Abbott Gmbh & Co. KgFormulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
US20060153889A1 (en)*2005-01-102006-07-13Friel Francis MDiscontinuous surface coating for particles
US20060251807A1 (en)*2005-05-062006-11-09Hong Keith CRoofing Granules With Improved Surface Coating Coverage And Functionalities And Method For Producing Same
US7140874B2 (en)2001-08-062006-11-28Southwest Research InstituteMethod and apparatus for testing catalytic converter durability
US20070003624A1 (en)*2005-06-292007-01-04Shanbhag Anant RSemi-permeable compositions providing reduced drying time for osmotic dosage forms
US20070031496A1 (en)*2005-08-042007-02-08Edgren David EOsmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties
WO2007053698A2 (en)2005-10-312007-05-10Alza CorporationMethods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms
US20070148342A1 (en)*2005-12-232007-06-28Kalkanoglu Husnu MControlled time-release algae resistant roofing system
US20070190137A1 (en)*2005-10-072007-08-16Reyes IranOsmotic dosage form with controlled release and fast release aspects
US20070281018A1 (en)*2004-09-242007-12-06Abbott LaboratoriesSustained release formulations of opioid and nonopioid analgesics
US20080051411A1 (en)*2002-12-172008-02-28Cink Russell DSalts of Fenofibric Acid and Pharmaceutical Formulations Thereof
US20080152714A1 (en)*2005-04-082008-06-26Yi GaoPharmaceutical Formulations
US20080214629A1 (en)*2007-02-092008-09-04Scott BullControlled release compositions of tizanidine
US20090022798A1 (en)*2007-07-202009-01-22Abbott Gmbh & Co. KgFormulations of nonopioid and confined opioid analgesics
US20090087484A1 (en)*2007-09-282009-04-02Alza CorporationFormulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
EP2074992A1 (en)2005-04-082009-07-01Abbott LaboratoriesPharmaceutical formulations
US20090233874A1 (en)*2007-09-102009-09-17Abdel-Magid Ahmed FProcess for the preparation of compounds useful as inhibitors of sglt
US20090317355A1 (en)*2006-01-212009-12-24Abbott Gmbh & Co. Kg,Abuse resistant melt extruded formulation having reduced alcohol interaction
US20100047524A1 (en)*2003-06-202010-02-25Hong Keith CAlgae resistant roofing granules with controlled algaecide leaching rates, algae resistant shingles and process for producing same
US20100099883A1 (en)*2008-10-172010-04-22Walter Ferdinand Maria FillersProcess for the preparation of compounds useful as inhibitors of sglt
US7749356B2 (en)2001-03-072010-07-06Kimberly-Clark Worldwide, Inc.Method for using water insoluble chemical additives with pulp and products made by said method
US20100172989A1 (en)*2006-01-212010-07-08Abbott LaboratoriesAbuse resistant melt extruded formulation having reduced alcohol interaction
US20100189878A1 (en)*2009-01-262010-07-29Teva Pharmaceutical Industries Ltd.Processes for coating a carrier with microparticles
US20100291208A1 (en)*2006-10-162010-11-18Jingang WangControlled porous osmotic pump tablets of high permeable drugs and the preparation process thereof
WO2011005811A1 (en)2009-07-082011-01-13Janssen Pharmaceutical NvCombination therapy for the treatment of diabetes
US20110087017A1 (en)*2009-10-142011-04-14Vittorio FarinaProcess for the preparation of compounds useful as inhibitors of sglt2
US20110159240A1 (en)*2009-11-242011-06-30Ming Liang ShiaoComposite nanoparticles for roofing granules, roofing shingles containing such granules, and process for producing same
US20110217515A1 (en)*2003-06-202011-09-08Hong Keith CAlgae resistant roofing granules with controlled algaecide leaching rates, algae resistant shingles and process for producing same
WO2011143296A1 (en)2010-05-112011-11-17Janssen Pharmaceutica NvPharmaceutical formulations comprising 1 - (beta-d-glucopyranosyl) - 2 -thienylmethylbenzene derivatives as inhibitors of sglt
WO2012006298A2 (en)2010-07-062012-01-12Janssen Pharmaceutica NvFormulation for co-therapy treatment of diabetes
US8354124B2 (en)2002-12-132013-01-15Durect CorporationOral drug delivery system
US20130040042A1 (en)*2011-08-092013-02-14Biomet Biologics, LlcSurgical Mesh Spray and Delivery System
EP2306792A3 (en)*2009-09-242013-04-17Fachhochschule Hildesheim / Holzminden / GöttingenMethod and device for handling objects with a physical plasma at atmospheric pressure
US8772512B2 (en)2009-07-102014-07-08Janssen Pharmaceutica NvCrystallisation process for 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl] benzene
WO2014179453A1 (en)2013-04-302014-11-06Abbvie, Inc.Methods for improving lipid profiles using atrasentan
US9035044B2 (en)2011-05-092015-05-19Janssen Pharmaceutica NvL-proline and citric acid co-crystals of (2S, 3R, 4R, 5S,6R)-2-(3-((5-(4-fluorophenyl)thiopen-2-yl)methyl)4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
US9226907B2 (en)2008-02-012016-01-05Abbvie Inc.Extended release hydrocodone acetaminophen and related methods and uses thereof
US9555113B2 (en)2013-03-152017-01-31Durect CorporationCompositions with a rheological modifier to reduce dissolution variability
US9592204B2 (en)2007-12-062017-03-14Durect CorporationOral pharmaceutical dosage forms
US9616055B2 (en)2008-11-032017-04-11Durect CorporationOral pharmaceutical dosage forms
US10052290B2 (en)2016-02-042018-08-21Billion King International Ltd.Enteric-coated hemoglobin multiparticulate for oral delivery of hemoglobin based oxygen carriers
US10544135B2 (en)2011-04-132020-01-28Janssen Pharmaceutica NvProcess for the preparation of compounds useful as inhibitors of SGLT2
US10730799B2 (en)2016-12-312020-08-04Certainteed CorporationSolar reflective composite granules and method of making solar reflective composite granules
WO2021029430A1 (en)2019-08-132021-02-18大塚製薬株式会社Oral pharmaceutical composition containing heterocyclic compound
US11197829B2 (en)*2018-08-222021-12-14Shenzhen ScienCare Medical Industries Co. Ltd.Preparation method of naltrexone implants
US11207337B2 (en)2015-09-152021-12-28Janssen Pharmaceutica NvCo-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
WO2022072193A1 (en)2020-09-302022-04-07Danisco Us IncCoated granules produced by in-situ crosslinking process
EP4480977A1 (en)2023-06-232024-12-25CertainTeed LLCPolyurethane-based coatings and coated substrates
US12274794B2 (en)2016-07-062025-04-15Orient Pharma Co., Ltd.Oral dosage form with drug composition, barrier layer and drug layer

Citations (9)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US1473165A (en)*1922-12-041923-11-06Steigmeyer FrederickSeed-conditioning apparatus
US1546922A (en)*1925-07-21Process oe desiccation
US1854100A (en)*1930-02-211932-04-12Brito Augusto DiazProcess of preparing material for pavements
US2114377A (en)*1935-03-011938-04-19Carlisle Lumber CompanyMeans for applying coatings
US2227465A (en)*1938-06-111941-01-07Binks Mfg CoMeans for eliminating divided material in industrial processes
US2339932A (en)*1941-04-101944-01-25Standard Oil Dev CoChemical process
US2561392A (en)*1945-08-111951-07-24Donald E MarshallProcess and apparatus for treating solutions to recover and coat solid particles
US2563475A (en)*1951-08-07Apparatus fob treating granular
US2648609A (en)*1949-01-211953-08-11Wisconsin Alumni Res FoundMethod of applying coatings to edible tablets or the like

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US1546922A (en)*1925-07-21Process oe desiccation
US2563475A (en)*1951-08-07Apparatus fob treating granular
US1473165A (en)*1922-12-041923-11-06Steigmeyer FrederickSeed-conditioning apparatus
US1854100A (en)*1930-02-211932-04-12Brito Augusto DiazProcess of preparing material for pavements
US2114377A (en)*1935-03-011938-04-19Carlisle Lumber CompanyMeans for applying coatings
US2227465A (en)*1938-06-111941-01-07Binks Mfg CoMeans for eliminating divided material in industrial processes
US2339932A (en)*1941-04-101944-01-25Standard Oil Dev CoChemical process
US2561392A (en)*1945-08-111951-07-24Donald E MarshallProcess and apparatus for treating solutions to recover and coat solid particles
US2648609A (en)*1949-01-211953-08-11Wisconsin Alumni Res FoundMethod of applying coatings to edible tablets or the like

Cited By (276)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US2944512A (en)*1956-07-171960-07-12Martin CoMethod and apparatus for spray painting small articles
US3075885A (en)*1957-07-121963-01-29Marissal GeorgesProcess for the stabilization by physical means of thermomineral planktonic complexes
US2986475A (en)*1958-11-051961-05-30Smith Kline French LabApparatus and method for coating discrete solids
US3089824A (en)*1959-04-301963-05-14Wisconsin Alumui Res FoundatioGranulating and coating process for uniform granules
DE1158481B (en)*1959-11-091963-12-05Wisconsin Alumni Res Found Process for coating particles with a coating material in a fluidized bed
US3117027A (en)*1960-01-081964-01-07Wisconsin Alumni Res FoundApparatus for coating particles in a fluidized bed
DE1205497B (en)*1960-02-261965-11-25Abbott Lab Method of applying a coating to finely divided discrete, preferably fragile, particles
US3177845A (en)*1960-07-111965-04-13Wood B HedgepethDevice for cooling and finishing foods
US3132075A (en)*1960-10-171964-05-05Upjohn CoSolid medicinal dosage forms coated with hydroxyethylcellulose and hydrolyzed styrene-maleic anhydride copolymer
US3148070A (en)*1961-03-241964-09-08Afico SaAromatization of powdered coffee products
US3106492A (en)*1961-09-011963-10-08Upjohn CoApparatus for coating discrete solids
US3145146A (en)*1961-10-311964-08-18Warner Lambert PharmaceuticalModified mannitol for pharmaceutical tablets
DE1184459B (en)*1962-01-201964-12-31Boehringer & Soehne Gmbh Coating process
US3357398A (en)*1962-09-281967-12-12Abbott LabMethod and apparatus for coating tablets
US3253944A (en)*1964-01-131966-05-31Wisconsin Alumni Res FoundParticle coating process
US3411480A (en)*1964-01-311968-11-19Smith Kline French LabDevice for coating fine solids
US3533829A (en)*1965-12-141970-10-13Azote & Prod ChimProcess and apparatus for solidifying and granulating a paste
US3880116A (en)*1974-02-141975-04-29Arnar Stone LabParticle coating apparatus
US4044713A (en)*1974-02-201977-08-30Zenyaku Kogyo Kabushiki KaishaTumbing apparatus
US4141316A (en)*1976-01-231979-02-27Gustav GrunApparatus for the treatment of powdery or granular material
US4764380A (en)*1982-03-221988-08-16Alza CorporationDrug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
US4639383A (en)*1983-09-201987-01-27Thomas Engineering, Inc.Method and apparatus for coating particulate granules
US4615698A (en)*1984-03-231986-10-07Alza CorporationTotal agent osmotic delivery system
AT385169B (en)*1984-11-201988-02-25Thaelmann Schwermaschbau VebMethod for the treatment of plant seeds
AT385170B (en)*1984-11-201988-02-25Thaelmann Schwermaschbau VebMethod for the application of agricultural chemicals to seeds
US4772477A (en)*1986-10-171988-09-20Balchem CorporationMeat acidulant
US4803092A (en)*1986-10-171989-02-07Balchem CorporationMethod of acidulating a comminuted meat product
US4801461A (en)*1987-01-281989-01-31Alza CorporationPseudoephedrine dosage form
US4851232A (en)*1987-02-131989-07-25Alza CorporationDrug delivery system with means for obtaining desirable in vivo release rate pattern
US5023076A (en)*1987-02-271991-06-11Alza CorporationLamina comprising carboxyvinyl polymer
US4915952A (en)*1987-02-271990-04-10Alza CorporationComposition comprising drug, HPC, HPMC and PEO
US4931285A (en)*1988-04-281990-06-05Alza CorporationAqueous based pharmaceutical coating composition for dosage forms
US5024842A (en)*1988-04-281991-06-18Alza CorporationAnnealed coats
US6056992A (en)*1988-06-022000-05-02Campbell Soup CompanyEncapsulated additives
US5096716A (en)*1988-09-011992-03-17Alza CorporationDosage form for administering calcium antagonist nicardipine
US4969884A (en)*1988-12-281990-11-13Alza CorporationOsmotically driven syringe
US5186942A (en)*1989-01-301993-02-16Alza CorporationNicardipine therapy
US5019396A (en)*1989-05-121991-05-28Alza CorporationDelivery dispenser for treating cardiac arrhythmias
US5024843A (en)*1989-09-051991-06-18Alza CorporationOral hypoglycemic glipizide granulation
US5035897A (en)*1989-09-051991-07-30Alza CorporationDosage form for delivering soluble or insoluble drugs
US5091190A (en)*1989-09-051992-02-25Alza CorporationDelivery system for administration blood-glucose lowering drug
US6361795B1 (en)1989-09-052002-03-26Alza CorporationMethod for lowering blood glucose
USRE44459E1 (en)1989-09-052013-08-27Alza CorporationMethod for lowering blood glucose
US5591454A (en)*1989-09-051997-01-07Alza CorporationMethod for lowering blood glucose
US5545413A (en)*1989-09-051996-08-13Alza CorporationDosage form for administering oral hypoglycemic glipizide
US5098714A (en)*1989-11-161992-03-24Alza CorporationOsmotic, oral dosage form for fertility control
US5842476A (en)*1989-11-161998-12-01Alza CorporationMethod for controlling fertility
US5200197A (en)*1989-11-161993-04-06Alza CorporationContraceptive pill
US5018909A (en)*1990-04-131991-05-28Nordson CorporationPowder feed hopper
US5296219A (en)*1990-06-151994-03-22Rhone-Poulenc Nutrition AnimaleProcess for coating active principles using a pH-sensitive polymer
US5166145A (en)*1990-09-101992-11-24Alza CorporationAntiemetic therapy
US5310561A (en)*1990-09-101994-05-10Alza CorporationAntiemetic therapy
US5190775A (en)*1991-05-291993-03-02Balchem CorporationEncapsulated bioactive substances
US6013286A (en)*1991-05-292000-01-11Balchem CorporationEncapsulated bioactive substances
US5178867A (en)*1991-08-191993-01-12Alza CorporationDosage form for delivering drug in short-time period
US5207933A (en)*1991-08-281993-05-04The Procter & Gamble CompanyLiquid fabric softener with insoluble particles stably suspended by soil release polymer
US5234611A (en)*1991-08-281993-08-10The Procter & Gamble CompanyFabric softener, preferably liquid, with protected, dryer-activated, cyclodextrin/perfume complex
US5236615A (en)*1991-08-281993-08-17The Procter & Gamble CompanySolid, particulate detergent composition with protected, dryer-activated, water sensitive material
US5232613A (en)*1991-08-281993-08-03The Procter & Gamble CompanyProcess for preparing protected particles of water sensitive material
US5232612A (en)*1991-08-281993-08-03The Procter & Gamble CompanySolid, particulate fabric softener with protected, dryer-activated, cyclodextrin/perfume complex
US5200194A (en)*1991-12-181993-04-06Alza CorporationOral osmotic device
US5246710A (en)*1992-02-271993-09-21Alza CorporationDosage form for treating cyclothymia
US5688518A (en)*1992-02-271997-11-18Alza CorporationAntidepressive therapy
US5858407A (en)*1992-02-271999-01-12Alza CorporationMethod for administering tandospirone
US5330762A (en)*1992-02-271994-07-19Alza CorporationTandospiaine antidepressive therapy
US5185158A (en)*1992-02-271993-02-09Alza CorporationDosage form comprising succinimide drug for treating depressive disorders and composition comprising same
US5246711A (en)*1992-02-271993-09-21Alza CorporationDosage form for treating dysthymia
US5254168A (en)*1992-06-041993-10-19Howard LittmanCoating apparatus having opposed atomizing nozzles in a fluid bed column
US5616339A (en)*1992-09-181997-04-01Rhone-Poulenc Nutrition AnimaleChitosan-based nutrient or medicinal compositions for administration to ruminants
EP0588707A1 (en)1992-09-181994-03-23Rhone-Poulenc Nutrition AnimaleChitosan-based nutrient and drug compositions for administration to ruminants
US5358721A (en)*1992-12-041994-10-25Alza CorporationAntiviral therapy
US5350659A (en)*1993-03-311994-09-27Xerox CorporationPreparation of conductive toners using fluidized bed processing equipment
US8084059B2 (en)1993-05-272011-12-27Alza CorporationAntidepressant dosage form
US6440457B1 (en)1993-05-272002-08-27Alza CorporationMethod of administering antidepressant dosage form
US20070009600A1 (en)*1993-05-272007-01-11Edgren David EAntidepressant dosage form
US20040086570A1 (en)*1993-05-272004-05-06Edgren David EmilAntidepressant dosage form
US20040092601A1 (en)*1993-05-272004-05-13Edgren David EmilAntidepressant dosage form
US6287598B1 (en)1993-05-282001-09-11Alza CorporationMethod for providing sustained antiepileptic therapy
US5707663A (en)*1993-05-281998-01-13Alza CorporationSustained antiepileptic therapy
US5980943A (en)*1993-05-281999-11-09Alza CorporationSustained antiepileptic therapy
US5532003A (en)*1994-01-181996-07-02Alza CorporationPentoxifylline therapy
US5603954A (en)*1994-01-181997-02-18Alza CorporationPentoxifylline therapy and method of use
US5540665A (en)*1994-01-311996-07-30Alza CorporationGas driven dispensing device and gas generating engine therefor
US5660861A (en)*1994-04-281997-08-26Alza CorporationEffective therapy for epilepsies
US5906832A (en)*1994-04-281999-05-25Alza CorporationMethod for treating epilepsies
US5863558A (en)*1994-04-281999-01-26Alza CorporationEffective therapy for epilepsies
US5955103A (en)*1994-04-281999-09-21Alza CorporationDosage form comprising antiepileptic drug
US20040191314A1 (en)*1994-04-282004-09-30Frank JaoAntiepileptic dosage form and process for protecting antiepileptic drug
US5876750A (en)*1994-04-281999-03-02Alza CorporationEffective therapy for epilepsies
US6036973A (en)*1994-06-272000-03-14Alza CorporationTherapy for neurological diseases
US5698224A (en)*1994-06-271997-12-16Alza CorporationTacrine therapy
US20010038856A1 (en)*1994-07-072001-11-08Sonya MerrillHydromorphone therapy
US20100028389A1 (en)*1994-07-072010-02-04Sonya MerrillHydromorphone therapy
US5620705A (en)*1994-08-041997-04-15Alza CorporationProgestin tablet
US5633011A (en)*1994-08-041997-05-27Alza CorporationProgesterone replacement therapy
US5770227A (en)*1994-08-041998-06-23Alza CorporationProgesterone replacement therapy
US5614578A (en)*1994-10-281997-03-25Alza CorporationInjection-molded dosage form
US5830502A (en)*1994-10-281998-11-03Alza CorporationInjection-molded dosage form
US5595759A (en)*1994-11-101997-01-21Alza CorporationProcess for providing therapeutic composition
US6274190B1 (en)1994-12-062001-08-14Coating Machinery Systems, Inc.Method of coating particulate material
US5567238A (en)*1994-12-061996-10-22Coating Machinery Systems, Inc.Oscillating bed seed coating machine for particulate material
US6919092B2 (en)1995-05-222005-07-19Alza CorporationMethod for the management of incontinence
US6262115B1 (en)1995-05-222001-07-17Alza CoporationMethod for the management of incontinence
US6124355A (en)*1995-05-222000-09-26Guittard; George V.Oxybutynin therapy
US20050238709A1 (en)*1996-11-122005-10-27Alza CorporationMethods and devices for providing prolonged drug therapy
US6930129B2 (en)1996-11-122005-08-16Alza CorporationMethods and devices for providing prolonged drug therapy
US8163798B2 (en)1996-11-122012-04-24Alza CorporationMethods and devices for providing prolonged drug therapy
US9144549B2 (en)1996-11-122015-09-29Alza CorporationMethods and devices for providing prolonged drug therapy
US20050025832A1 (en)*1996-11-122005-02-03Alza CorporationMethods and devices for providing prolonged drug therapy
US20100093796A1 (en)*1996-11-122010-04-15Gupta Suneel KMethods and devices for providing prolonged drug therapy
US8629179B2 (en)1996-11-122014-01-14Alza CorporationMethods and devices for providing prolonged drug therapy
US9000038B2 (en)1996-11-122015-04-07Alza CorporationMethods and devices for providing prolonged drug therapy
US20050025831A1 (en)*1996-11-122005-02-03Alza CorporationMethods and devices for providing prolonged drug therapy
US6919373B1 (en)1996-11-122005-07-19Alza CorporationMethods and devices for providing prolonged drug therapy
US9029416B2 (en)1996-11-122015-05-12Alza CorporationMethods and devices for providing prolonged drug therapy
US6110499A (en)*1997-07-242000-08-29Alza CorporationPhenytoin therapy
US20020098242A1 (en)*1997-07-312002-07-25Darder Carlos PicornellOral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production
US7060734B1 (en)1997-09-092006-06-13Alza CorporationPharmaceutical coating composition and method of use
US7087243B2 (en)1997-09-092006-08-08Edgren David EPharmaceutical coating composition and method of use
US6514530B2 (en)1997-09-092003-02-04Alza CorporationDosage form comprising means for changing drug delivery shape
US20050003006A1 (en)*1997-09-092005-01-06Alza CorporationPharmaceutical coating composition and method of use
US20040062799A1 (en)*1997-09-292004-04-01Ayer Atul D.Therapeutic composition and delivery system for administering drug
US6210712B1 (en)1997-12-052001-04-03Alza CorporationDosage form having first and second coats
US20010009995A1 (en)*1998-03-262001-07-26Gupta Suneel K.Oxybutynin therapy
US20020160045A1 (en)*1998-06-052002-10-31Desjardin Michael A.Therapeutic dosage form for delivering oxybutynin
US6855334B2 (en)1998-11-022005-02-15Alta CorporationControlled delivery of active agents
US20020048600A1 (en)*1998-11-022002-04-25Padmanabh BhattControlled delivery of active agents
EP1652516A2 (en)1998-11-022006-05-03ALZA CorporationOsmotic controlled delivery of active agents
US6706282B1 (en)1998-11-022004-03-16Evangeline CruzControlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
US6312521B1 (en)1998-12-142001-11-06Primera Foods CorporationApparatus and process for coating particles
US6596314B2 (en)1998-12-232003-07-22Alza CorporationControlled release liquid active agent formulation dosage forms
US6342249B1 (en)1998-12-232002-01-29Alza CorporationControlled release liquid active agent formulation dosage forms
US7407551B2 (en)1999-04-192008-08-05Boston Scientific Scimed, Inc.Mechanical and acoustical suspension coating of medical implants
US6368658B1 (en)1999-04-192002-04-09Scimed Life Systems, Inc.Coating medical devices using air suspension
WO2000062830A3 (en)*1999-04-192000-12-28Scimed Life Systems IncCoating medical devices using air suspension
US20110034993A1 (en)*1999-04-192011-02-10Boston Scientific Scimed, Inc.Coated medical implants
EP1649937A1 (en)*1999-04-192006-04-26Boston Scientific LimitedCoating medical device using air suspension
US20040089230A1 (en)*1999-04-192004-05-13Schwarz Marlene C.Mechanical and acoustical suspension coating of medical implants
US6730349B2 (en)1999-04-192004-05-04Scimed Life Systems, Inc.Mechanical and acoustical suspension coating of medical implants
US20020071863A1 (en)*1999-12-092002-06-13Dong Liang C.Antiviral medication
US20050220879A1 (en)*1999-12-162005-10-06Alza CorporationDosage forms having a barrier layer to laser ablation
US7011850B2 (en)1999-12-162006-03-14Alza CorporationDosage forms having a barrier layer to laser ablation
US6379498B1 (en)2000-02-282002-04-30Kimberly-Clark Worldwide, Inc.Method for adding an adsorbable chemical additive to pulp during the pulp processing and products made by said method
US6740406B2 (en)2000-12-152004-05-25Kimberly-Clark Worldwide, Inc.Coated activated carbon
US20030159786A1 (en)*2001-03-072003-08-28Runge Troy MichaelMethod for using water insoluble chemical additives with pulp and products made by said method
US6582560B2 (en)2001-03-072003-06-24Kimberly-Clark Worldwide, Inc.Method for using water insoluble chemical additives with pulp and products made by said method
US7749356B2 (en)2001-03-072010-07-06Kimberly-Clark Worldwide, Inc.Method for using water insoluble chemical additives with pulp and products made by said method
US20100243187A1 (en)*2001-03-072010-09-30Troy Michael RungeMethod for Applying Chemical Additives to Pulp During the Pulp Processing and Products Made by Said Method
US7993490B2 (en)2001-03-072011-08-09Kimberly-Clark Worldwide, Inc.Method for applying chemical additives to pulp during the pulp processing and products made by said method
US6984290B2 (en)2001-03-072006-01-10Kimberly-Clark Worldwide, Inc.Method for applying water insoluble chemical additives with to pulp fiber
US20080070169A1 (en)*2001-08-062008-03-20Ingalls Melvin NMethod and apparatus for testing catalytic converter durability
US7140874B2 (en)2001-08-062006-11-28Southwest Research InstituteMethod and apparatus for testing catalytic converter durability
US7625201B2 (en)2001-08-062009-12-01Southwest Research InstituteMethod and apparatus for testing catalytic converter durability
US20030062641A1 (en)*2001-08-162003-04-03Niraj VasishthaMicroencapsulation using electromagnetic energy and core and shell materials with different dielectric constants and dissipation factors
US6881482B2 (en)2001-08-162005-04-19Southwest Research InstituteMicroencapsulation using electromagnetic energy and core and shell materials with different dielectric constants and dissipation factors
US6767553B2 (en)2001-12-182004-07-27Kimberly-Clark Worldwide, Inc.Natural fibers treated with acidic odor control/binder systems
US20030125714A1 (en)*2001-12-182003-07-03Edgren David EmilDosage form for time-varying patterns of drug delivery
US20070207204A1 (en)*2001-12-182007-09-06Alza CorporationDosage Form for Time-Varying Patterns of Drug Delivery
US6852904B2 (en)2001-12-182005-02-08Kimberly-Clark Worldwide, Inc.Cellulose fibers treated with acidic odor control agents
US20030198619A1 (en)*2001-12-192003-10-23Dong Liang C.Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
US20030232078A1 (en)*2001-12-192003-12-18Dong Liang C.Formulation & dosage form for the controlled delivery of therapeutic agents
US6685775B1 (en)2002-02-192004-02-03Vector CorporationWurster air diverter
US20030165614A1 (en)*2002-03-012003-09-04Henrik HansenCoating a medical implant using a pan coater
US20040010000A1 (en)*2002-04-292004-01-15Ayer Atul D.Methods and dosage forms for controlled delivery of oxycodone
US20050106249A1 (en)*2002-04-292005-05-19Stephen HwangOnce-a-day, oral, controlled-release, oxycodone dosage forms
US20030224051A1 (en)*2002-05-312003-12-04Fink Tracy A.Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
US20040091529A1 (en)*2002-06-262004-05-13David EdgrenMethods and dosage forms for increasing solubility of drug compositions for controlled delivery
US20040115262A1 (en)*2002-07-292004-06-17Frank JaoFormulations and dosage forms for controlled delivery of topiramate
US9393192B2 (en)2002-07-292016-07-19Alza CorporationMethods and dosage forms for controlled delivery of paliperidone and risperidone
US20050232995A1 (en)*2002-07-292005-10-20Yam Nyomi VMethods and dosage forms for controlled delivery of paliperidone and risperidone
US20040115315A1 (en)*2002-08-022004-06-17Camelot Damien Michel AndreEncapsulated crystalline lactic acid
US7687092B2 (en)2002-08-022010-03-30Purac Biochem B.V.Encapsulated crystalline lactic acid
US20040045687A1 (en)*2002-09-112004-03-11Shannon Thomas GerardMethod for using water insoluble chemical additives with pulp and products made by said method
US9233160B2 (en)2002-12-132016-01-12Durect CorporationOral drug delivery system
US9517271B2 (en)2002-12-132016-12-13Durect CorporationOral drug delivery system
US9918982B2 (en)2002-12-132018-03-20Durect CorporationOral drug delivery system
US8420120B2 (en)2002-12-132013-04-16Durect CorporationOral drug delivery system
US8354124B2 (en)2002-12-132013-01-15Durect CorporationOral drug delivery system
US7259186B2 (en)2002-12-172007-08-21Abbott LaboratoriesSalts of fenofibric acid and pharmaceutical formulations thereof
US20050148594A1 (en)*2002-12-172005-07-07Cink Russell D.Salts of fenofibric acid and pharmaceutical formulations thereof
US20060134196A1 (en)*2002-12-172006-06-22Abbott Gmbh & Co. KgFormulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
US20080051411A1 (en)*2002-12-172008-02-28Cink Russell DSalts of Fenofibric Acid and Pharmaceutical Formulations Thereof
US20040166160A1 (en)*2003-01-142004-08-26Ramkumar SubramanianMethods and dosage forms with modified viscosity layers
US20040197407A1 (en)*2003-02-112004-10-07Ramkumar SubramanianMethods and dosage forms with modified layer geometry
US8039048B2 (en)2003-06-202011-10-18Certainteed CorporationAlgae resistant roofing granules with controlled algaecide leaching rates, algae resistant shingles and process for producing same
US20110217515A1 (en)*2003-06-202011-09-08Hong Keith CAlgae resistant roofing granules with controlled algaecide leaching rates, algae resistant shingles and process for producing same
US8668954B2 (en)2003-06-202014-03-11Certainteed CorporationAlgae resistant roofing granules with controlled algaecide leaching rates, algae resistant shingles and process for producing same
US10876294B2 (en)2003-06-202020-12-29Certainteed LlcAlgae resistant roofing granules with controlled algaecide leaching rates, algae resistant shingles, and process for producing same
US20100047524A1 (en)*2003-06-202010-02-25Hong Keith CAlgae resistant roofing granules with controlled algaecide leaching rates, algae resistant shingles and process for producing same
US20050058707A1 (en)*2003-08-062005-03-17Iran ReyesUniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
US20050136108A1 (en)*2003-08-222005-06-23Yam Noymi V.Stepwise delivery of topiramate over prolonged period of time
US20050069587A1 (en)*2003-09-022005-03-31Modi Nishit BachulalNovel drug compositions and dosage forms of topiramate
US20050112195A1 (en)*2003-09-262005-05-26Evangeline CruzDrug coating providing high drug loading and methods for providing same
US20050089570A1 (en)*2003-09-262005-04-28Evangeline CruzOros push-stick for controlled delivery of active agents
US20060251721A1 (en)*2003-09-262006-11-09Evangeline CruzControlled release formulations of opioid and nonopioid analgesics
US20050158382A1 (en)*2003-09-262005-07-21Evangeline CruzControlled release formulations of opioid and nonopioid analgesics
US8246986B2 (en)2003-09-262012-08-21Alza CorporationDrug coating providing high drug loading
US8226979B2 (en)2003-09-262012-07-24Alza CorporationDrug coating providing high drug loading and methods for providing the same
US20050169992A1 (en)*2003-12-232005-08-04Frank JaoMethods and dosage forms for increasing solubility of drug compositions for controlled delivery
US20050175696A1 (en)*2003-12-292005-08-11David EdgrenDrug granule coatings that impart smear resistance during mechanical compression
US20050175697A1 (en)*2003-12-292005-08-11David EdgrenNovel drug compositions and dosage forms of topiramate
US20050175690A1 (en)*2003-12-292005-08-11David EdgrenNovel drug compositions and dosage forms
US20060009425A1 (en)*2004-05-282006-01-12Leticia Delgado-HerreraOral formulations of paricalcitol
US20050287212A1 (en)*2004-06-282005-12-29Liang-Chang DongOral delivery system comprising a drug/polymer complex
US20050287213A1 (en)*2004-06-282005-12-29Wong Patrick SDosage forms for low solubility and or low dissolution rate free acid pharmaceutical agents
US20060057206A1 (en)*2004-08-192006-03-16Wong Patrick SControlled release nanoparticle active agent formulation dosage forms and methods
US8541026B2 (en)2004-09-242013-09-24Abbvie Inc.Sustained release formulations of opioid and nonopioid analgesics
US20070281018A1 (en)*2004-09-242007-12-06Abbott LaboratoriesSustained release formulations of opioid and nonopioid analgesics
WO2006061576A1 (en)*2004-12-112006-06-15Apv Systems LimitedFood item coating apparatus and method
US20060153889A1 (en)*2005-01-102006-07-13Friel Francis MDiscontinuous surface coating for particles
EP2074992A1 (en)2005-04-082009-07-01Abbott LaboratoriesPharmaceutical formulations
US20110237675A1 (en)*2005-04-082011-09-29Abbott LaboratoriesPharmaceutical formulations
US20080152714A1 (en)*2005-04-082008-06-26Yi GaoPharmaceutical Formulations
US20060251807A1 (en)*2005-05-062006-11-09Hong Keith CRoofing Granules With Improved Surface Coating Coverage And Functionalities And Method For Producing Same
US20070003624A1 (en)*2005-06-292007-01-04Shanbhag Anant RSemi-permeable compositions providing reduced drying time for osmotic dosage forms
US20070031496A1 (en)*2005-08-042007-02-08Edgren David EOsmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties
US20070190137A1 (en)*2005-10-072007-08-16Reyes IranOsmotic dosage form with controlled release and fast release aspects
WO2007053698A2 (en)2005-10-312007-05-10Alza CorporationMethods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms
US20090221621A1 (en)*2005-10-312009-09-03Alza CorporationMethods of Reducing Alcohol-Induced Dose Dumping for Opioid Sustained Release Oral Dosage Forms
US20070148342A1 (en)*2005-12-232007-06-28Kalkanoglu Husnu MControlled time-release algae resistant roofing system
US20100172989A1 (en)*2006-01-212010-07-08Abbott LaboratoriesAbuse resistant melt extruded formulation having reduced alcohol interaction
US20090317355A1 (en)*2006-01-212009-12-24Abbott Gmbh & Co. Kg,Abuse resistant melt extruded formulation having reduced alcohol interaction
US8703193B2 (en)*2006-10-162014-04-22Cosci Med-Tech Co. Ltd.Controlled porous osmotic pump tablets of high permeable drugs and the preparation process thereof
US20100291208A1 (en)*2006-10-162010-11-18Jingang WangControlled porous osmotic pump tablets of high permeable drugs and the preparation process thereof
US8524749B2 (en)2007-02-092013-09-03Alza CorporationControlled release compositions of tizanidine
US20080214629A1 (en)*2007-02-092008-09-04Scott BullControlled release compositions of tizanidine
US20090022798A1 (en)*2007-07-202009-01-22Abbott Gmbh & Co. KgFormulations of nonopioid and confined opioid analgesics
US20090233874A1 (en)*2007-09-102009-09-17Abdel-Magid Ahmed FProcess for the preparation of compounds useful as inhibitors of sglt
US9024009B2 (en)2007-09-102015-05-05Janssen Pharmaceutica N.V.Process for the preparation of compounds useful as inhibitors of SGLT
US20090087484A1 (en)*2007-09-282009-04-02Alza CorporationFormulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
US9592204B2 (en)2007-12-062017-03-14Durect CorporationOral pharmaceutical dosage forms
US9655861B2 (en)2007-12-062017-05-23Durect CorporationOral pharmaceutical dosage forms
US10206883B2 (en)2007-12-062019-02-19Durect CorporationOral pharamaceutical dosage forms
US9226907B2 (en)2008-02-012016-01-05Abbvie Inc.Extended release hydrocodone acetaminophen and related methods and uses thereof
US20100099883A1 (en)*2008-10-172010-04-22Walter Ferdinand Maria FillersProcess for the preparation of compounds useful as inhibitors of sglt
US9056850B2 (en)2008-10-172015-06-16Janssen Pharmaceutica N.V.Process for the preparation of compounds useful as inhibitors of SGLT
US9616055B2 (en)2008-11-032017-04-11Durect CorporationOral pharmaceutical dosage forms
US10328068B2 (en)2008-11-032019-06-25Durect CorporationOral pharmaceutical dosage forms
US9884056B2 (en)2008-11-032018-02-06Durect CorporationOral pharmaceutical dosage forms
WO2010085780A1 (en)2009-01-262010-07-29Teva Pharmaceutical Industries Ltd.Processes for coating a carrier with microparticles
US8889213B2 (en)2009-01-262014-11-18Teva Pharmaceutical Industries Ltd.Processes for coating a carrier with microparticles
US20100189878A1 (en)*2009-01-262010-07-29Teva Pharmaceutical Industries Ltd.Processes for coating a carrier with microparticles
US11576894B2 (en)2009-07-082023-02-14Janssen Pharmaceutica NvCombination therapy for the treatment of diabetes
WO2011005811A1 (en)2009-07-082011-01-13Janssen Pharmaceutical NvCombination therapy for the treatment of diabetes
US20110009347A1 (en)*2009-07-082011-01-13Yin LiangCombination therapy for the treatment of diabetes
US8772512B2 (en)2009-07-102014-07-08Janssen Pharmaceutica NvCrystallisation process for 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl] benzene
EP2306792A3 (en)*2009-09-242013-04-17Fachhochschule Hildesheim / Holzminden / GöttingenMethod and device for handling objects with a physical plasma at atmospheric pressure
US9174971B2 (en)2009-10-142015-11-03Janssen Pharmaceutica NvProcess for the preparation of compounds useful as inhibitors of SGLT2
US20110087017A1 (en)*2009-10-142011-04-14Vittorio FarinaProcess for the preparation of compounds useful as inhibitors of sglt2
US11433366B2 (en)2009-11-242022-09-06Certainteed LlcComposite nanoparticles for roofing granules, roofing shingles containing such granules, and process for producing same
US9540822B2 (en)2009-11-242017-01-10Certainteed CorporationComposite nanoparticles for roofing granules, roofing shingles containing such granules, and process for producing same
US20110159240A1 (en)*2009-11-242011-06-30Ming Liang ShiaoComposite nanoparticles for roofing granules, roofing shingles containing such granules, and process for producing same
US10617668B2 (en)2010-05-112020-04-14Janssen Pharmaceutica NvPharmaceutical formulations
WO2011143296A1 (en)2010-05-112011-11-17Janssen Pharmaceutica NvPharmaceutical formulations comprising 1 - (beta-d-glucopyranosyl) - 2 -thienylmethylbenzene derivatives as inhibitors of sglt
WO2012006298A2 (en)2010-07-062012-01-12Janssen Pharmaceutica NvFormulation for co-therapy treatment of diabetes
US10544135B2 (en)2011-04-132020-01-28Janssen Pharmaceutica NvProcess for the preparation of compounds useful as inhibitors of SGLT2
US9035044B2 (en)2011-05-092015-05-19Janssen Pharmaceutica NvL-proline and citric acid co-crystals of (2S, 3R, 4R, 5S,6R)-2-(3-((5-(4-fluorophenyl)thiopen-2-yl)methyl)4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
US9345623B2 (en)2011-08-092016-05-24Biomet Biologics, LlcSurgical mesh spray and delivery system
US8776716B2 (en)*2011-08-092014-07-15Biomet Biologics, LlcSurgical mesh spray and delivery system
US20130040042A1 (en)*2011-08-092013-02-14Biomet Biologics, LlcSurgical Mesh Spray and Delivery System
US10300142B2 (en)2013-03-152019-05-28Durect CorporationCompositions with a rheological modifier to reduce dissolution variability
US9555113B2 (en)2013-03-152017-01-31Durect CorporationCompositions with a rheological modifier to reduce dissolution variability
US9572885B2 (en)2013-03-152017-02-21Durect CorporationCompositions with a rheological modifier to reduce dissolution variability
US9855333B2 (en)2013-03-152018-01-02Durect CorporationCompositions with a rheological modifier to reduce dissolution variability
US9907851B2 (en)2013-03-152018-03-06Durect CorporationCompositions with a rheological modifier to reduce dissolution variability
WO2014179453A1 (en)2013-04-302014-11-06Abbvie, Inc.Methods for improving lipid profiles using atrasentan
US11207337B2 (en)2015-09-152021-12-28Janssen Pharmaceutica NvCo-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
US10052290B2 (en)2016-02-042018-08-21Billion King International Ltd.Enteric-coated hemoglobin multiparticulate for oral delivery of hemoglobin based oxygen carriers
US12274794B2 (en)2016-07-062025-04-15Orient Pharma Co., Ltd.Oral dosage form with drug composition, barrier layer and drug layer
US11453614B2 (en)2016-12-312022-09-27Certainteed LlcSolar reflective composite granules and method of making solar reflective composite granules
US10730799B2 (en)2016-12-312020-08-04Certainteed CorporationSolar reflective composite granules and method of making solar reflective composite granules
US11197829B2 (en)*2018-08-222021-12-14Shenzhen ScienCare Medical Industries Co. Ltd.Preparation method of naltrexone implants
WO2021029429A1 (en)2019-08-132021-02-18大塚製薬株式会社Oral pharmaceutical composition
WO2021029430A1 (en)2019-08-132021-02-18大塚製薬株式会社Oral pharmaceutical composition containing heterocyclic compound
WO2022072193A1 (en)2020-09-302022-04-07Danisco Us IncCoated granules produced by in-situ crosslinking process
EP4480977A1 (en)2023-06-232024-12-25CertainTeed LLCPolyurethane-based coatings and coated substrates

Similar Documents

PublicationPublication DateTitle
US2799241A (en)Means for applying coatings to tablets or the like
US2648609A (en)Method of applying coatings to edible tablets or the like
US3196827A (en)Apparatus for the encapsulation of discrete particles
US3117027A (en)Apparatus for coating particles in a fluidized bed
US3253944A (en)Particle coating process
US2986475A (en)Apparatus and method for coating discrete solids
US3112220A (en)Method and apparatus for coating particles
US6449869B1 (en)Device and method for drying pourable products
US2862511A (en)Apparatus for liquid treatment of granular material
GB1299839A (en)Hot air type drying apparatus
US3238063A (en)Continuous centrifugal apparatus and method of continuously separating granular crystals therewith
US4275682A (en)Peanut seed treating machine
JPS63501059A (en) Anti-coring grain processing equipment
US3662474A (en)Dryers and method of operation
US3179379A (en)Apparatus for treatment of powdered and granular material
US2341101A (en)Method and apparatus for dehydrating natural plants and grasses
US4320584A (en)Fluidized bed apparatus
US3029000A (en)Flocking device
US1725608A (en)Process and apparatus for coating granular material
US2559989A (en)Spray drier
US1946566A (en)Method of conditioning spray dried products and apparatus therefor
US3175686A (en)Method and apparatus for cooling and reconditioning molding sand
US1019958A (en)Sugar-drier.
US2957519A (en)Spray drying apparatus and method
US1169599A (en)Grain conditioning and tempering machine.

[8]ページ先頭

©2009-2025 Movatter.jp